Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
88.84
0.00 (0.00%)
At close: Dec 24, 2025, 4:00 PM EST
89.30
+0.46 (0.52%)
Pre-market: Dec 26, 2025, 4:13 AM EST

Protagonist Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
5,5542,3001,3235371,632867
Upgrade
Market Cap Growth
130.10%73.94%146.40%-67.12%88.22%352.15%
Upgrade
Enterprise Value
4,8861,7281,0022741,286674
Upgrade
Last Close Price
88.8438.6022.9310.9134.2020.16
Upgrade
PE Ratio
123.358.36----
Upgrade
PS Ratio
26.815.3022.0420.1959.6730.29
Upgrade
PB Ratio
8.603.413.932.495.443.10
Upgrade
P/TBV Ratio
8.603.413.932.495.443.10
Upgrade
P/FCF Ratio
87.1712.59----
Upgrade
P/OCF Ratio
84.8312.49----
Upgrade
EV/Sales Ratio
23.353.9816.6910.2947.0123.53
Upgrade
EV/EBITDA Ratio
243.936.81----
Upgrade
EV/EBIT Ratio
257.046.84----
Upgrade
EV/FCF Ratio
76.699.45----
Upgrade
Debt / Equity Ratio
0.020.020.000.020.020.02
Upgrade
Debt / EBITDA Ratio
0.470.04----
Upgrade
Debt / FCF Ratio
0.170.06----
Upgrade
Asset Turnover
0.320.790.200.090.080.12
Upgrade
Quick Ratio
12.9412.3916.547.617.557.69
Upgrade
Current Ratio
13.0512.4816.717.807.747.84
Upgrade
Return on Equity (ROE)
7.80%54.39%-28.59%-49.41%-43.32%-36.79%
Upgrade
Return on Assets (ROA)
1.82%28.66%-19.32%-27.57%-23.40%-16.82%
Upgrade
Return on Capital (ROIC)
1.98%30.86%-21.01%-31.27%-26.60%-21.08%
Upgrade
Return on Capital Employed (ROCE)
2.90%36.30%-27.80%-60.60%-41.40%-22.70%
Upgrade
Earnings Yield
0.83%11.96%-5.97%-23.73%-7.69%-7.63%
Upgrade
FCF Yield
1.15%7.95%-5.36%-20.29%-6.68%-8.41%
Upgrade
Buyback Yield / Dilution
-0.97%-14.65%-15.74%-5.87%-34.67%-32.84%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q